A New Cancer vaccine is ready for human trial | DocMode
A New Cancer vaccine is ready for human trial

Unlike standard vaccines designed to prevent diseases such as polio, smallpox or measles directly, cancer vaccines do not target the disease directly. But still vaccines are important to preventing and treating other cancers. Recently, a new cancer vaccine was developed by Lead Researcher Associate professor Kristen Radford and her mater research team working at The Translational Research Institute in partnership with Queensland University.

After the positive outcome of preclinical studies, the scientists are ready to launch human trials of the new cancer vaccine. This cancer vaccine has the potential for the treatment of a variety of blood cancers and malignancies, and is a major breakthrough in cancer vaccination. According to Kristen this vaccine may be used to treat blood cancers such as myeloid leukaemia, non-Hodgkin’s lymphoma, multiple myeloma and pediatric leukaemia, plus strong malignancies including breast , lung, renal, ovarian and pancreatic cancers, and glioblastoma. Our new vaccine is comprised of human antibodies fused with tumour-specific protein, and we are investigating its capacity to target human cells while activating the memory of the tumour cells.”she says

Professor Radford says the vaccine offers a few key advantages over previous cancer vaccines mainly for two reasons, which in early clinical trials have already shown promise:

  • Firstly, it can be developed as a clinical grade formulation ‘off the shelf,’ which circumvents the financial and logistical problems associated with individual patient vaccines.
  • Second, this innovative vaccine targets the primary tumor cells needed to activate tumor-specific immune responses, optimizing potential treatment efficacy while reducing potential side effects.

This new cancer vaccine promises to benefit cancer patients in the future and shows results to be a safe and effective cancer vaccine. 

 

Tag Cloud

Follow us on Facebook

Follow us on Twitter